Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy
2010 ◽
Vol 40
(4)
◽
pp. 313-318
◽
2010 ◽
Vol 16
(30)
◽
pp. 3853
◽
1323 mTOR expression in gastrointestinal (GI) tract poorly differentiated endocrine carcinoma (PDEC)
2009 ◽
Vol 7
(2)
◽
pp. 145-146
◽
2007 ◽
Vol 203
(12)
◽
pp. 879-884
◽
2009 ◽
Vol 74
(2)
◽
pp. 48-49
◽
1999 ◽
Vol 116
(3)
◽
pp. 532-542
◽
Keyword(s):